JB170

JB170


JB170 is a highly specific PROTAC degrader of AURORA-A, created by connecting Alisertib to a Cereblon-binding molecule, Thalidomide. This compound selectively binds to AURORA-A, demonstrating a strong preference over AURORA-B. JB170 effectively induces S-phase arrest through targeted AURORA-A depletion, while also inhibiting its non-catalytic functions.

Molecular structure of the compound BP-42263
    • Unit
    • Price
    • Qty
    • 1 MG
    • $150.00
    • 5 MG
    • $430.00
    • 10 MG
    • $750.00
    • 25 MG
    • $1300.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire